Brussels, Belgium

Abdelaziz El Khloufi

This inventor holds 1 USPTO granted patent. Top assignee: Pharmachemie B.v.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abdelaziz El Khloufi. Retrieved from https://idiyas.com/inventor/abdelaziz-el-khloufi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Abdelaziz El Khloufi

Introduction

Abdelaziz El Khloufi is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of anti-tumor research. His work focuses on developing innovative compounds that can potentially combat cancer.

Latest Patents

Abdelaziz holds 1 patent for his invention titled "Organo-tin compounds having anti-tumour activity." This patent relates to anti-tumor compositions that contain as an active ingredient one or more compounds of a specific formula. His research aims to provide new therapeutic options for cancer treatment.

Career Highlights

Throughout his career, Abdelaziz has demonstrated a commitment to advancing medical science. His work has been recognized for its potential impact on cancer therapies. He continues to explore new avenues in research and development.

Collaborations

Abdelaziz has collaborated with esteemed colleagues, including Mohammad Boualam and Dirk De Vos. These partnerships have fostered a productive environment for innovation and discovery.

Conclusion

Abdelaziz El Khloufi's contributions to anti-tumor research highlight the importance of innovation in the medical field. His work exemplifies the potential of scientific advancements to improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…